Axil Brands, Inc.
AXILNYSEConsumer Staples · Perfumes, Cosmetics & Other Toilet Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $26.3M | $27.5M | $23.5M | $2.3M | $1.6M | $1.0M |
| Operating income | $1.2M | $1.5M | $2.0M | −$211,403 | −$321,054 | −$171,119 |
| Net income | $854,988 | $2.0M | $1.8M | −$182,903 | −$297,755 | −$172,767 |
| Total assets | $12.9M | $11.0M | $10.2M | $893,915 | $1.3M | $1.1M |
| Total liabilities | $3.2M | $3.3M | $3.5M | $709,203 | $917,116 | $638,299 |
| Equity | $9.7M | $7.7M | $6.7M | $184,712 | $345,648 | $504,603 |
| EPS (diluted) | $0.10 | $0.21 | $0.10 | $0.00 | — | — |
| Shares out. | 6.7M | 6.4M | 117.1M | 115.0M | 41.9M | 41.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 4.4%
- Net margin
- 3.3%
- Return on equity
- 8.9%
- Return on assets
- 6.6%
- Return on capital (ROCE)
- 11.2%
- Liabilities / assets
- 24.9%
- Debt / equity
- 0.33×
- Book value / share
- $1.45
- Revenue growth (YoY)
- −4.5%
- Net income growth (YoY)
- −57.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 7.41safe
- Accruals / assets
- −8.3%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 5 good- Revenue declined year-over-year
- Operating margin is positive
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 64,031 | 1.2 | -75.9% |
| Apr 30, 2026 | 266,137 | 1.0 | +1328.5% |
| Apr 15, 2026 | 18,631 | 1.5 | -35.8% |
| Mar 31, 2026 | 29,027 | 1.9 | -11.9% |
| Mar 13, 2026 | 32,936 | 2.5 | -9.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsApr 8, 2026
- Director / officer changeJan 20, 2026
- Results of operationsJan 8, 2026
- Shareholder voteDec 17, 2025
- Results of operationsOct 7, 2025
- Results of operationsAug 21, 2025
- Amended charter or bylawsMay 19, 2025
- Results of operationsApr 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KCURRENT REPORTApr 8, 2026
- 10-QFORM 10-Q FOR PERIOD ENDING FEBRUARY 28, 2026Apr 8, 2026
- 4Mar 4, 2026
- 4Jan 20, 2026
- 3Jan 20, 2026
- 4Jan 20, 2026
- 8-KCURRENT REPORTJan 20, 2026
- 8-KCURRENT REPORTJan 8, 2026
- 10-Q10-Q FOR PERIOD ENDING NOVEMBER 30/2025Jan 8, 2026
- 8-KCURRENT REPORTDec 17, 2025
- SCHEDULE 13D/ANov 3, 2025
- 4Nov 3, 2025
- SCHEDULE 13D/AOct 30, 2025
- 4Oct 30, 2025
- ARSOct 23, 2025